Association between the functional polymorphism in the matrix metalloproteinase-7 promoter and susceptibility to adult astrocytoma

Brain Research

Volumn 1118, Issue 1, 2006, Pages 6-12

  Lu, Zhongqiang ^a   Wang, Yimin ^a   Zhang, Qingjun ^b   Zhang, Xianghong ^a   Wang, Shuheng ^a   Xie, Huiling ^a   Li, Yuehong ^a   Jiao, Baohua ^a   Zhang, Jianhui ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

Astrocytoma; Glioma; Matrix metalloproteinase 7; Single nucleotide polymorphism; Susceptibility

Indexed keywords

MATRILYSIN;

ADULT; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER RISK; CANCER SUSCEPTIBILITY; CHINA; CONTROLLED STUDY; FEMALE; GENDER; GENETIC POLYMORPHISM; GENOTYPE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; AGE FACTORS; ASTROCYTOMA; BRAIN NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; MALE; MATRIX METALLOPROTEINASE 7; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); SEX FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 33750305078     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.08.007     Document Type: Article

References (40)

1. Barille S., Bataille R., Rapp M.J., Harousseau J.L., and Amiot M. Production of metalloproteinase-7 (matrilysin) by human myeloma cells and its potential involvement in metalloproteinase-2 activation. J. Immunol. 163 (1999) 5723-5728 (Abstract | Full Text+Links | PDF(880K) PDF(880K))
2. Egeblad M., and Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev., Cancer 2 (2002) 161-174
3. Fang S., Jin X., Wang R., Li Y., Guo W., Wang N., Wang Y., Wen D., Wei L., and Zhang J. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China. Carcinogenesis 26 (2005) 481-486 (Abstract | Full Text+Links | PDF(86K) PDF(86K))
4. Fingleton B., Vargo-Gogola T., Crawford H.C., and Matrisian L.M. Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis. Neoplasia 3 (2001) 459-468
5. Fiotti N., Zivadinov R., Altamura N., Nasuelli D., Bratina A., Tommasi M.A., Bosco A., Locatelli L., Grop A., Cazzato G., Guarnieri G., Giansante C., and Zorzon M. MMP-9 microsatellite polymorphism and multiple sclerosis. J. Neuroimmunol. 152 (2004) 147-153
6. Ghilardi G., Biondi M.L., Erario M., Guagnellini E., and Scorza R. Colorectal carcinoma susceptibility and metastases are associated with matrix metalloproteinase-7 promoter polymorphisms. Clin. Chem. 49 (2003) 1940-1942 (Abstract | Full Text+Links | PDF(76K))
7. Gumbiner B.M. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84 (1996) 345-357 (Abstract | Full Text+Links | PDF(138K) PDF(138K))
8. Haro H., Crawford H.C., Fingleton B., Shinomiya K., Spengler D.M., and Matrisian L.M. Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption. J. Clin. Invest. 105 (2000) 143-150 (Abstract | Full Text+Links | PDF(217K) PDF(217K))
9. Ichimura K., Ohgaki H., Kleihues P., and Collins V.P. Molecular pathogenesis of astrocytic tumours. J. Neuro-Oncol. 70 (2004) 137-160
10. Jormsjo S., Whatling C., Walter D.H., Zeiher A.M., Hamsten A., and Eriksson P. Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients. Arterioscler., Thromb., Vasc. Biol. 21 (2001) 1834-1839 (Abstract | Full Text+Links | PDF(123K))
11. Louis D.N., and Stemmer-Rachamimov A.O. Pathology and classification. In: Bernstein M., and Berger M. (Eds). Neuro-Oncology: The Essentials (2000), Thieme Medical Publishers, New York 18-29
12. Malmer B., Grönberg H., Bergenheim A.T., Lenner P., and Henriksson R. Familial aggregation of astrocytoma in northern Sweden: an epidemiological cohort study. Int. J. Cancer 81 (1999) 366-370 (Abstract | Full Text+Links | PDF(59K) PDF(59K))
13. Mattey D.L., Nixon N.B., Dawes P.T., Ollier W.E., and Hajeer A.H. Association of matrix metalloproteinase 3 promoter genotype with disease outcome in rheumatoid arthritis. Genes Immun. 5 (2004) 147-149
14. Miller S.A., Dybes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res. 16 (1988) 1215
15. Newell K.J., Matrisian L.M., and Driman D.K. Matrilysin (matrix metalloproteinase-7) expression in ulcerative colitis-related tumorigenesis. Mol. Carcinog. 34 (2002) 59-63
16. Noe V., Fingleton B., Jacobs K., Crawford H.C., Vermeulen S., Steelant W., Bruyneel E., Matrisian L.M., and Mareel M. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J. Cell Sci. 114 (2001) 111-118
17. Nojiri T., Morita H., Imai Y., Maemura K., Ohno M., Ogasawara K., Aizawa T., Saito A., Hayashi D., Hirata Y., Sugiyama T., Yamazaki T., and Nagai R. Genetic variations of matrix metalloproteinase-1 and-3 promoter regions and their associations with susceptibility to myocardial infarction in Japanese. Int. J. Cardiol. 92 (2003) 181-186
18. Parhar P., Ezer R., Shao Y., Allen J.C., Miller D.C., and Newcomb E.W. Possible association of p53 codon 72 polymorphism with susceptibility to adult and pediatric high-grade astrocytomas. Brain Res. Mol. Brain Res. 137 (2005) 98-103
19. Parsons S.L., Watson S.A., Brown P.D., Collins H.M., and Steele R.J. Matrix metalloproteinases. Br. J. Surg. 84 (1997) 160-166
20. Powell W.C., Fingleton B., Wilson C.L., Boothby M., and Matrisian L.M. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Curr. Biol. 9 (1999) 1441-1447 (Abstract | Full Text+Links | PDF(120K) PDF(120K))
21. Quantin B., Murphy G., and Breathnach R. Pump-1 cDNA codes for a protein with characteristics similar to those of classical collagenase family members. Biochemistry 28 (1989) 5327-5334
22. Rajaraman P., Schwartz B.S., Rothman N., Yeager M., Fine H.A., Shapiro W.R., Selker R.G., Black P.M., and Inskip P.D. Delta-aminolevulinic acid dehydratase polymorphism and risk of brain tumors in adults. Environ. Health Perspect. 113 (2005) 1209-1211 (Abstract | Full Text+Links | PDF(130K) PDF(130K))
23. Schwartzbaum J., Ahlbom A., Malmer B., Lonn S., Brookes A.J., Doss H., Debinski W., Henriksson R., and Feychting M. Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. Cancer Res. 65 (2005) 6459-6465
24. Takahashi I., Onodera K., Bae J.W., Mitani H., Sasano Y., and Mitani H. Age-related changes in the expression of gelatinase and tissue inhibitor of metalloproteinase genes in mandibular condylar, growth plate, and articular cartilage in rats. J. Mol. Histol. 36 (2005) 355-366
25. Thorns V., Walter G.F., and Thorns C. Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas. Anticancer Res. 23 (2003) 3937-3944
26. Thrailkill K.M., Moreau C.S., Cockrell G., Simpson P., Goel R., North P., Fowlkes J.L., and Bunn R.C. Physiological matrix metalloproteinase concentrations in serum during childhood and adolescence, using Luminex Multiplex technology. Clin. Chem. Lab. Med. 43 (2005) 1392-1399
27. Vargo-Gogola T., Fingleton B., Crawford H.C., and Matrisian L.M. Matrilysin (matrix metalloproteinase-7) selects for apoptosis-resistant mammary cells in vivo. Cancer Res. 62 (2002) 5559-5563 (Abstract | Full Text+Links | PDF(397K) PDF(397K))
28. Vince G.H., Wagner S., Pietsch T., Klein R., Goldbrunner R.H., Roosen K., and Tonn J.C. Heterogeneous regional expression patterns of matrix metalloproteinases in human malignant gliomas. Int. J. Dev. Neurosci. 17 (1999) 437-445
29. Wagner S., Stegen C., Bouterfa H., Huettner C., Kerkau S., Roggendorf W., Roosen K., and Tonn J.C. Expression of matrix metalloproteinases in human glioma cell lines in the presence of IL-10. J. Neuro-Oncol. 40 (1998) 113-122
30. Wiemels J.L., Wiencke J.K., Sison J.D., Miike R., McMillan A., and Wrensch M. History of allergies among adults with glioma and controls. Int. J. Cancer 98 (2002) 609-615
31. Wiemels J.L., Wiencke J.K., Patoka J., Moghadassi M., Chew T., McMillan A., Miike R., Barger G., and Wrensch M. Reduced immunoglobulin E and allergy among adults with glioma compared with controls. Cancer Res. 64 (2004) 8468-8473 (Abstract | Full Text+Links | PDF(110K) PDF(110K))
32. Wilson C.L., Heppner K.J., Labosky P.A., Hogan B.L., and Matrisian L.M. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 1402-1407 (Abstract | Full Text+Links | PDF(415K) PDF(415K))
33. Witty J.P., McDonnell S., Newell K.J., Cannon P., Navre M., Tressler R.J., and Matrisian L.M. Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo. Cancer Res. 54 (1994) 4805-4812
34. Woodrum D.T., Ford J.W., Ailawadi G., Pearce C.G., Sinha I., Eagleton M.J., Henke P.K., Stanley J.C., and Upchurch Jr. G.R. Gender differences in rat aortic smooth muscle cell matrix metalloproteinase-9. J. Am. Coll. Surg. 201 (2005) 398-404
35. Wrensch M., Kelsey K.T., Liu M., Miike R., Moghadassi M., Aldape K., McMillan A., and Wiencke J.K. Glutathione-S-transferase variants and adult glioma. Cancer Epidemiol., Biomarkers Prev. 13 (2004) 461-467 (Abstract | Full Text+Links | PDF(83K) PDF(83K))
36. Wrensch M., Fisher J.L., Schwartzbaum J.A., Bondy M., Berger M., and Aldape K.D. The molecular epidemiology of gliomas in adults. Neurosurg. Focus 19 (2005) E5
37. Ye S. Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases. Matrix Biol. 19 (2000) 623-629
38. Yu C., Pan K., Xing D., Liang G., Tan W., Zhang L., and Lin D. Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer. Cancer Res. 62 (2002) 6430-6433 (Abstract | Full Text+Links | PDF(59K) PDF(59K))
39. Zhang J., Jin X., Fang S., Li Y., Wang R., Guo W., Wang N., Wang Y., Wen D., Wei L., Kuang G., and Dong Z. The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastases in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma. Carcinogenesis 25 (2004) 2519-2524 (Abstract | Full Text+Links | PDF(102K) PDF(102K))
40. Zhang J., Jin X., Fang S., Wang R., Li Y., Wang N., Guo W., Wang Y.M., Wen D., Wei L., Dong Z.M., and Kuang G. The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma. Carcinogenesis 26 (2005) 1748-1753